Study Reports Possible Novel Method for Stopping Untreatable Pediatric Brain Cancer
Effective Treatment Options Lacking for Leading Killer of Kids with Cancer
Researchers used an experimental molecular therapy in preclinical laboratory tests to effectively treat several types of deadly pediatric brain cancer and now propose advancing the treatment to clinical testing in children.
Scientists at the Cincinnati Children’s Cancer and Blood Diseases Institute report testing the small molecule 6-thio-2’deoxyguanosine (6-thio-dG) in brain cancer stem cells derived from tumor cells donated by patients. Researchers also tested the treatment in humanized mouse models of pediatric brain cancer.
The cancers include intrinsic pontine glioma (DIPG), high-grade glioma (HGG) and high-risk medulloblastoma (MB).
Click here to read more.
2018 Advanced Endoscopic Skull Base and Pituitary Surgery
June 1-2, 2018; New York
2018 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting
June 2-5, 2018; Denver
Complex Endoscopic Endonasal Surgery of the Skull Base
June 7-9, 2018; Pittsburgh, PA
2018 Annual Meeting of the Michigan Association of Neurological Surgeons
June 8-10, 2018; Thompsonville, MI
CARS 2018 Computer Assisted Radiology and Surgery
June 20-23, 2018; Berlin, Germany
Be the first to reply using the above form.